ABVD Regimen: — Drugs, Cycles and Side Effects

Hair loss with ABVD is temporary. It generally begins within the first few weeks as the drugs affect fast-dividing cells, including those in hair follicles, and it returns after treatment ends. Texture and thickness at regrowth can differ at first but usually normalise. If the prospect of hair loss is distressing — and it often is — raising it with your team before treatment starts means you can discuss options such as cold capping, if it is available at your centre.

Bleomycin changes how lung tissue responds to high concentrations of oxygen. This sensitivity does not reliably resolve after treatment ends, which means any surgeon or anaesthesiologist treating you in future — even many years later — needs to know about it before planning a procedure. Elevated oxygen given during surgery can trigger or worsen bleomycin lung damage in people who received it, sometimes severely. Ask your oncology team for a written treatment summary listing the drugs you received, and keep it with your medical records.

Report it to your oncology team the same day, rather than waiting for your next scheduled appointment. A new dry cough or shortness of breath during ABVD is a specific signal that needs assessment, because it can indicate bleomycin affecting the lung. It may turn out to be unrelated — a viral infection, for instance — but that distinction is one your team needs to make, not one to wait on. Early reporting is what keeps the available management options open.

A PET-CT uses a radioactive tracer to show which areas of the body have metabolically active tissue, including lymphoma. The scan done partway through ABVD — sometimes called an interim PET — assesses how the lymphoma is responding before the full course is complete. The result can inform decisions about the remaining cycles. This scan is a planned part of treatment, not a response to a problem; being called for it does not mean something unexpected has happened.

Many people continue working, at least partly, during ABVD, though it depends on the nature of the work, the commute, and individual tolerance of each cycle. The day of infusion and the following day tend to be the most difficult for nausea and fatigue. Work involving physical effort or close contact with many people — because of infection risk — may need to be adjusted more than desk-based or remote work. Discuss your specific situation with your oncologist, who can advise based on your blood count pattern and how you are responding.

Most side effects begin to resolve once treatment ends. Nausea typically settles quickly. Hair returns within a few months, though the timeline varies. Fatigue is often the most persistent — many people find it takes several months to return to their usual energy levels, and recovery tends to be gradual rather than sudden. The bleomycin lung risk is different: it does not follow the same recovery curve, and the need to disclose it to future healthcare providers does not have an expiry date.